|
Press Releases |
|
 |
|
Tuesday, August 7, 2012 |
|
Q&A: MediciNova CEO, Dr. Yuichi Iwaki on His Firm's Pipeline, Upcoming Milestones and Recent Clinical Trial Results |
Dr. Yuichi Iwaki, President and CEO of Nasdaq listed small-cap MediciNova, Inc. (NASDAQ:MNOV) took the time to answer BioMedReports' questions about his firm's pipeline, upcoming milestones and recent clinical trial results. more info >> |
|
Thursday, August 2, 2012 |
|
Amicus Therapeutics: Strong Catalyst Trade With GlaxoSmithKline And Heavy Insider Buying |
I like to invest in and trade companies with strong corporate structures that are also equipped with upcoming short term catalysts. more info >> |
|
Doomed Dendreon? Many Speculators Shocked By Poor Sales Again |
Dendreon (DNDN) has been a disastrous holding for many investors who may have been initially optimistic about the company's drug PROVENGE. more info >> |
|
Wednesday, August 1, 2012 |
|
Former Chairman and CEO of Celgene Believes His New Firm Can Become "A Substantial Player" in Biotech |
No doubt, one of the biggest biotech surprises out of the starting gate this year has been Medgenics Inc. (AMEX:MDGN). The stock ran big shortly after their introduction to the market as shares traded from $2.08 to $16.43 in short order-- an impressive run fueled in part by the company's extremely low float and excited reaction by investors. more info >> |
|
Tuesday, July 31, 2012 |
|
Pluristem Therapeutics' New Indication for Pulmonary and Lung Disorders Expands Blockbuster Pipeline |
This morning, Pluristem Therapeutics (NASDAQ:PSTI) is once again making news. This time, with a new way to treat Pulmonary fibrosis; where a person's lungs become so scarred that breathing is impossible. more info >> |
|
Pluristem's New Indication for Pulmonary and Lung Disorders Expands Blockbuster Pipeline |
This morning, Pluristem Therapeutics (PSTI) is once again making news. This time with a new way to treat Pulmonary fibrosis; where a person's lungs become so scarred that breathing is impossible. It strikes 5 million people per year around the world, and 200,000 in the US. Most die because there is no cure. more info >> |
|
Friday, July 27, 2012 |
|
Roth Capital Says Amarin's Approval Provides Visibility for Neptune Reiterates Buy Rating and $10.30 Price Target |
In a flash note to clients on Friday, Roth Capital Partners' analyst Joseph Pantginis, Ph.D.,says that Thursday's FDA approval for Amarin Corporation's (NASDAQ:AMRN) Vascepa bodes well for Neptune Technologies & Bioressources' (Nasdaq:NEPT) (TSX:NTB) underlying and growing core NKO business as well as the pharmaceutical opportunity with Acasti's CaPre. more info >> |
|
Thursday, July 26, 2012 |
|
Short Squeeze & Speculation Could Push Onyx and Ligand Higher |
When I last covered Onyx Pharmaceuticals (NASDAQ:ONXX) on June 19th, the company was trading at a market capitalization of approximately $3 billion dollars ahead of a review of Kyprolis (carfilzomib) by the FDA's Oncologic Drugs Advisory Committee (ODAC). more info >> |
|
Monday, July 23, 2012 |
|
Pluristem Poised To Benefit From The Evolution of Regulatory Requirements |
Trying to find companies that represent the future of the biotech sector can be tricky for investors. The sector currently leads the market because Food and Drug Administration (FDA) regulatory guidance is changing, with restrictions easing, and new guidelines being proposed and implemented. more info >> |
|
New Reports Indicate That Brainstorm's Clinical Data is Compelling |
While BrainStorm Cell Therapeutics (OTCBB:BCLI) is expected to officially release their highly anticipated clinical data to U.S. investors shortly, two widely distributed overnight reports point to strong progress in the results of their mid-stage clinical trials. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
耀啟新程!康哲藥業今日於新加坡交易所主板實現二次上市
Jul 15, 2025 23:54 HKT/SGT
|
|
|
U.S. Polo Assn. Celebrates Seventh Year Supporting the 2025 Outsourcing Inc. Royal Charity Polo Cup
Jul 15, 2025 23:14 HKT/SGT
|
|
|
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
Jul 15, 2025 23:13 HKT/SGT
|
|
|
Formerra to Supply Foster Medical Compounds Across the Americas
Jul 15, 2025 22:50 HKT/SGT
|
|
|
Buy International Homes at the Global Property Expo, Singapore
Jul 15, 2025 20:06 HKT/SGT
|
|
|
XDS Datacentres signs 15-year deal to host 10MW of AI workloads in Saudi's Desert Dragons facilities
Jul 15, 2025 19:41 HKT/SGT
|
|
|
Ocean One Seizing Business Opportunities with Main Board Listing Application
Jul 15, 2025 19:00 HKT/SGT
|
|
|
大洋環球申轉主板上市捉緊商機 迎中國恢復部分日本水產進口機遇
Jul 15, 2025 18:22 HKT/SGT
|
|
|
大洋环球申转主板上市捉紧商机 迎中国恢复部分日本水产进口机遇
Jul 15, 2025 18:10 HKT/SGT
|
|
|
雲頂新耀股價創階段新高 通用型現貨腫瘤治療性疫苗EVM14「中美雙報」再釋mRNA平台潛力
Jul 15, 2025 17:40 HKT/SGT
|
|
|
云顶新耀股价创阶段新高 通用型现货肿瘤治疗性疫苗EVM14"中美双报"再释mRNA平台潜力
Jul 15, 2025 17:34 HKT/SGT
|
|
|
耀启新程!康哲药业今日于新加坡交易所主板实现二次上市
Jul 15, 2025 16:53 HKT/SGT
|
|
|
ONERHT Foundation Announces 8th edition of GAIL Forum which will focus on Green Leadership in ASEAN
Jul 15, 2025 13:00 HKT/SGT
|
|
|
PCG Collaborates with Big Boss Taxi and STAY BAR to Usher in a Cashless Era
Jul 15, 2025 12:30 HKT/SGT
|
|
|
交易寶攜手Big Boss Taxi與STAY BAR開啟無現金新時代
Jul 15, 2025 12:30 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|